EI
ENABLE INJECTIONS, INC
SEC filingOther Health Care · Cincinnati, OH
Amount raised$30Msold at filing
Total offering$30M
Investors in the raise1count reported to the SEC
FiledJan 9, 2026first sale Dec 29, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jim J. CollinsDirector
Simone D. SongDirector
Richard J. D'AugustineDirector
John J. RiceDirector
David D. KroekelExecutive Officer
John J. DeFordDirector
Matt D. HuddlestonExecutive Officer
Timothy FlahertyExecutive Officer
Beckie J. RobertsonDirector
Michael D. HoovenExecutive Officer, Director
Erik D. FalkDirector
Nigel J. SheailDirector
Executive officers, directors and promoters as listed on the Form D.